Rochelle, Virginia (December 27, 2016) – NDA Partners Chairman Carl Peck, MD, announced today that Dr. Steven Brooks, former Medical Officer, Peripheral Vascular Device Branch, Office of Device Evaluation at FDA US Food & Drug Administration (FDA), has joined the company as an Expert Consultant. Dr. Brooks was a key member of the FDA Medical Devices Reimbursement Task Force and a member of the FDA Entrepreneur-in-Residence Program to streamline the approval-to-reimbursement pathway for devices. In addition to his FDA experience, Dr. Brooks is currently a Medical Device Executive for the TEDCO mdPACE Program, TEDCO Life Science Investment Fund Reviewer, and Maryland Innovation Initiative (MII) Reviewer for the Maryland Technology Development Corporation (TEDCO). Dr. Brooks previously served as Vice President of Regulatory Affairs and Health Economics for Ablative Solutions (ASI); Chief Innovation Officer for Sage Growth Partners and is an active Senior Advisor for Popper and Company, a healthcare consulting firm focusing on healthcare technology.
Dr. Brooks is an expert Interventional Cardiologist, formerly as a faculty member at the University of Maryland Medical Center and then in private practice. He serves on several Advisory Boards including Glysend, Renalert, and Mammoth Health Innovation.
According to David Feigal, MD, MPH, head of the NDA Partners’ Medical Device Practice area, “Dr. Steven Brooks’ first-hand knowledge and experience of reimbursements and health technology assessment of medical devices, both at FDA and in the industry, make him an excellent addition to our team of Expert Consultants. We are delighted that he has joined the NDA Partners team.”
Dr. Brooks earned his MD from the University of Pittsburgh Medical Center and an MBA from Johns Hopkins Carey School of Business. He is an expert Interventional Cardiologist, formerly as a faculty member at the University of Maryland Medical Center and then in private practice.
About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.
Earle Martin, Chief Executive Officer